Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lobaplatin and 5-fluorouracil in Recurrent Nasopharyngeal Carcinoma
NCT03210389Phase 2Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Jul 2017
- Primary completion
- Dec 2019
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of lobaplatin in nasopharyngeal carcinoma (NPC), sponsored by Sun Yat-sen University. Primary endpoint: Progression-Free Survival at 2 years. Status: unknown.
02
Drugs
lobaplatin
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT03210389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03210389.